InvestorsHub Logo
Followers 28
Posts 2777
Boards Moderated 0
Alias Born 03/24/2019

Re: None

Thursday, 06/16/2022 12:54:45 PM

Thursday, June 16, 2022 12:54:45 PM

Post# of 36575
Exceptionally bullish however, I cannot begin to comprehend who is risking selling at this 11th hour stage of Revive's FDA Phase 3 Clinical Trial for Bucillamine in COVID-19. All indicators point towards a successful conclusion / achievement and subsequent announcement backed by the FDA - then it's likely "to the Moon" (via Coutts & Co.)